Correlation Between Fidelity MSCI and Franklin Genomic
Can any of the company-specific risk be diversified away by investing in both Fidelity MSCI and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity MSCI and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity MSCI Financials and Franklin Genomic Advancements, you can compare the effects of market volatilities on Fidelity MSCI and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity MSCI with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity MSCI and Franklin Genomic.
Diversification Opportunities for Fidelity MSCI and Franklin Genomic
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Fidelity and Franklin is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity MSCI Financials and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Fidelity MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity MSCI Financials are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Fidelity MSCI i.e., Fidelity MSCI and Franklin Genomic go up and down completely randomly.
Pair Corralation between Fidelity MSCI and Franklin Genomic
Given the investment horizon of 90 days Fidelity MSCI Financials is expected to generate 0.9 times more return on investment than Franklin Genomic. However, Fidelity MSCI Financials is 1.12 times less risky than Franklin Genomic. It trades about 0.09 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about 0.01 per unit of risk. If you would invest 4,726 in Fidelity MSCI Financials on September 1, 2024 and sell it today you would earn a total of 2,605 from holding Fidelity MSCI Financials or generate 55.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fidelity MSCI Financials vs. Franklin Genomic Advancements
Performance |
Timeline |
Fidelity MSCI Financials |
Franklin Genomic Adv |
Fidelity MSCI and Franklin Genomic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fidelity MSCI and Franklin Genomic
The main advantage of trading using opposite Fidelity MSCI and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity MSCI position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.Fidelity MSCI vs. Fidelity MSCI Industrials | Fidelity MSCI vs. Fidelity MSCI Health | Fidelity MSCI vs. Fidelity MSCI Materials | Fidelity MSCI vs. Fidelity MSCI Consumer |
Franklin Genomic vs. Fidelity MSCI Financials | Franklin Genomic vs. Fidelity MSCI Consumer | Franklin Genomic vs. Fidelity MSCI Consumer | Franklin Genomic vs. Fidelity MSCI Industrials |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |